535 related articles for article (PubMed ID: 7504992)
1. Activation of MAP kinases, pp90rsk and pp70-S6 kinases in mouse mast cells by signaling through the c-kit receptor tyrosine kinase or Fc epsilon RI: rapamycin inhibits activation of pp70-S6 kinase and proliferation in mouse mast cells.
Tsai M; Chen RH; Tam SY; Blenis J; Galli SJ
Eur J Immunol; 1993 Dec; 23(12):3286-91. PubMed ID: 7504992
[TBL] [Abstract][Full Text] [Related]
2. Stem cell factor augments Fc epsilon RI-mediated TNF-alpha production and stimulates MAP kinases via a different pathway in MC/9 mast cells.
Ishizuka T; Kawasome H; Terada N; Takeda K; Gerwins P; Keller GM; Johnson GL; Gelfand EW
J Immunol; 1998 Oct; 161(7):3624-30. PubMed ID: 9759885
[TBL] [Abstract][Full Text] [Related]
3. Murine KIT+ lineage- bone marrow progenitors express Fc gamma-RII but do not express Fc epsilon-RI until mast cell granule formation.
Lantz CS; Huff TF
J Immunol; 1995 Jan; 154(1):355-62. PubMed ID: 7527815
[TBL] [Abstract][Full Text] [Related]
4. MEK and ERK activation in ras-disabled RBL-2H3 mast cells and novel roles for geranylgeranylated and farnesylated proteins in Fc epsilonRI-mediated signaling.
Graham TE; Pfeiffer JR; Lee RJ; Kusewitt DF; Martinez AM; Foutz T; Wilson BS; Oliver JM
J Immunol; 1998 Dec; 161(12):6733-44. PubMed ID: 9862703
[TBL] [Abstract][Full Text] [Related]
5. Distinct patterns of early response gene expression and proliferation in mouse mast cells stimulated by stem cell factor, interleukin-3, or IgE and antigen.
Tsai M; Tam SY; Galli SJ
Eur J Immunol; 1993 Apr; 23(4):867-72. PubMed ID: 7681400
[TBL] [Abstract][Full Text] [Related]
6. Mitogen-activated protein kinase activation through Fc epsilon receptor I and stem cell factor receptor is differentially regulated by phosphatidylinositol 3-kinase and calcineurin in mouse bone marrow-derived mast cells.
Ishizuka T; Chayama K; Takeda K; Hamelmann E; Terada N; Keller GM; Johnson GL; Gelfand EW
J Immunol; 1999 Feb; 162(4):2087-94. PubMed ID: 9973482
[TBL] [Abstract][Full Text] [Related]
7. Activation of 70-kDa S6 kinase, induced by the cytokines interleukin-3 and erythropoietin and inhibited by rapamycin, is not an absolute requirement for cell proliferation.
Calvo V; Wood M; Gjertson C; Vik T; Bierer BE
Eur J Immunol; 1994 Nov; 24(11):2664-71. PubMed ID: 7957559
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of mitogen-activated protein kinase activity by different secretory stimuli in rat basophilic leukemia cells.
Offermanns S; Jones SV; Bombien E; Schultz G
J Immunol; 1994 Jan; 152(1):250-61. PubMed ID: 8254195
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of stem cell factor-induced proliferation of primitive murine hematopoietic progenitor cells signaled through the 75-kilodalton tumor necrosis factor receptor. Regulation of c-kit and p53 expression.
Jacobsen FW; Dubois CM; Rusten LS; Veiby OP; Jacobsen SE
J Immunol; 1995 Apr; 154(8):3732-41. PubMed ID: 7535812
[TBL] [Abstract][Full Text] [Related]
10. FK506 binding protein 12 mediates sensitivity to both FK506 and rapamycin in murine mast cells.
Fruman DA; Wood MA; Gjertson CK; Katz HR; Burakoff SJ; Bierer BE
Eur J Immunol; 1995 Feb; 25(2):563-71. PubMed ID: 7533090
[TBL] [Abstract][Full Text] [Related]
11. SCF/c-kit receptor-mediated arachidonic acid liberation in rat mast cells. Involvement of PLD activation associated tyrosine phosphorylation.
Koike T; Mizutani T; Hirai K; Morita Y; Nozawa Y
Biochem Biophys Res Commun; 1993 Dec; 197(3):1570-7. PubMed ID: 7506546
[TBL] [Abstract][Full Text] [Related]
12. Identification of a protein, SPY75, with repetitive helix-turn-helix motifs and an SH3 domain as a major substrate for protein tyrosine kinase(s) activated by Fc epsilon RI cross-linking.
Fukamachi H; Yamada N; Miura T; Kato T; Ishikawa M; Gulbins E; Altman A; Kawakami Y; Kawakami T
J Immunol; 1994 Jan; 152(2):642-52. PubMed ID: 7506729
[TBL] [Abstract][Full Text] [Related]
13. Engagement of the high-affinity IgE receptor activates src protein-related tyrosine kinases.
Eiseman E; Bolen JB
Nature; 1992 Jan; 355(6355):78-80. PubMed ID: 1370575
[TBL] [Abstract][Full Text] [Related]
14. IL-3-dependent murine mast cells undergo apoptosis on removal of IL-3. Prevention of apoptosis by c-kit ligand.
Mekori YA; Oh CK; Metcalfe DD
J Immunol; 1993 Oct; 151(7):3775-84. PubMed ID: 7690814
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of receptor-associated kinase, tyrosine kinase, and MAP kinase is required for prolactin-mediated macromolecular biosynthesis and mitogenesis in Nb2 lymphoma.
Carey GB; Liberti JP
Arch Biochem Biophys; 1995 Jan; 316(1):179-89. PubMed ID: 7840614
[TBL] [Abstract][Full Text] [Related]
16. Distinct mechanisms for the activation of the RSK kinases/MAP2 kinase/pp90rsk and pp70-S6 kinase signaling systems are indicated by inhibition of protein synthesis.
Blenis J; Chung J; Erikson E; Alcorta DA; Erikson RL
Cell Growth Differ; 1991 Jun; 2(6):279-85. PubMed ID: 1648378
[TBL] [Abstract][Full Text] [Related]
17. Akt cross-links IL-4 priming, stem cell factor signaling, and IgE-dependent activation in mature human mast cells.
Feuser K; Feilhauer K; Staib L; Bischoff SC; Lorentz A
Mol Immunol; 2011 Jan; 48(4):546-52. PubMed ID: 21106245
[TBL] [Abstract][Full Text] [Related]
18. An in vivo model for receptor tyrosine kinase autocrine/paracrine activation: auto-stimulated KIT receptor acts as a tumor promoting factor in papillomavirus-induced tumorigenesis.
Kondoh G; Hayasaka N; Li Q; Nishimune Y; Hakura A
Oncogene; 1995 Jan; 10(2):341-7. PubMed ID: 7530826
[TBL] [Abstract][Full Text] [Related]
19. Fyn kinase acts upstream of Shp2 and p38 mitogen-activated protein kinase to promote chemotaxis of mast cells towards stem cell factor.
Samayawardhena LA; Hu J; Stein PL; Craig AW
Cell Signal; 2006 Sep; 18(9):1447-54. PubMed ID: 16442778
[TBL] [Abstract][Full Text] [Related]
20. SH2 domain-containing phosphatase-2 protein-tyrosine phosphatase promotes Fc epsilon RI-induced activation of Fyn and Erk pathways leading to TNF alpha release from bone marrow-derived mast cells.
McPherson VA; Sharma N; Everingham S; Smith J; Zhu HH; Feng GS; Craig AW
J Immunol; 2009 Oct; 183(8):4940-7. PubMed ID: 19786542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
